| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.44B | 53.83B | 53.07B | 48.89B | 49.85B | 45.26B |
| Gross Profit | 11.22B | 11.08B | 10.65B | 8.99B | 8.95B | 6.48B |
| EBITDA | 6.16B | 5.58B | 6.19B | 4.69B | 5.08B | 3.38B |
| Net Income | 2.04B | 3.72B | 2.01B | 1.67B | 1.84B | 90.91M |
Balance Sheet | ||||||
| Total Assets | 80.34B | 82.36B | 80.27B | 77.93B | 70.74B | 69.43B |
| Cash, Cash Equivalents and Short-Term Investments | 12.94B | 13.05B | 13.99B | 12.80B | 12.04B | 11.02B |
| Total Debt | 28.74B | 16.74B | 17.32B | 32.42B | 31.89B | 22.35B |
| Total Liabilities | 45.33B | 46.21B | 46.56B | 48.14B | 46.20B | 46.38B |
| Stockholders Equity | 31.20B | 34.08B | 29.99B | 26.44B | 21.47B | 20.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.96B | 5.35B | 461.54M | 836.27M | 3.13B |
| Operating Cash Flow | 0.00 | 5.64B | 6.81B | 4.33B | 4.90B | 4.92B |
| Investing Cash Flow | 0.00 | -1.19B | -1.55B | -3.32B | -3.61B | -1.64B |
| Financing Cash Flow | 0.00 | -5.82B | -4.08B | -135.69M | -321.28M | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.61B | 5.39 | ― | 3.02% | 8.78% | 31.99% | |
65 Neutral | ¥21.57B | 6.04 | ― | 1.29% | 1.42% | 88.77% | |
64 Neutral | ¥9.97B | 2.10 | ― | 4.99% | 9.16% | 146.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥16.64B | 20.95 | ― | 1.38% | 8.18% | 40.68% | |
54 Neutral | ¥11.30B | 15.72 | ― | 1.87% | 1.90% | 24.92% | |
50 Neutral | ¥6.58B | -36.82 | ― | 0.30% | -2.80% | 3.74% |